Morphology of the major papilla predicts ERCP procedural outcomes and adverse events.
Rachid Mohamed, B Cord Lethebe, Emmanuel Gonzalez-Moreno...
https://pubmed.ncbi.nlm.nih.gov/33146812Actively Recruiting
Age: 18Years +
All Genders
ID04259580
Calgary Registry for Advanced and Therapeutic Endoscopy
Led by University of Calgary · Updated on 2026-04-29
6000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Calgary Registry for Advanced and Therapeutic Endoscopy (CReATE) is a high-quality, prospective study collecting data on adult patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) for biliary and pancreatic diseases. The registry aims to gather detailed information from multiple centers to better understand outcomes and complications related to this advanced endoscopic procedure. Participants undergo ERCP, an endoscopic procedure used to access biliary and pancreatic structures. The study observes patients consecutively from September 2018 to August 2022, capturing all relevant data before, during, and after the procedure. This includes procedural details and patient outcomes, serving also as a platform for additional prospective studies and randomized trials. During the study, a full-time research assistant collects real-time data by observing procedures directly. Participants are followed up with medical record reviews and phone interviews 30 days after the procedure to assess outcomes such as unplanned healthcare visits and procedure-related complications including pancreatitis, bleeding, and infections. The registry monitors technical success immediately and tracks patients' health for up to 30 days post-procedure, contributing to ongoing research until the study ends in 2030.
CONDITIONS
Brief Title
Calgary Registry for Advanced and Therapeutic Endoscopy
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Have a standard indication for ERCP
- Able and willing to give informed consent or accompanied by a surrogate who can consent
You will not qualify if you...
- Any standard contraindications for ERCP
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Single day
Participants undergo the endoscopic retrograde pancreatography (ERCP) procedure to access biliary and/or pancreatic structures.
1 visit (in-person)
Monitoring
Duration - 30 days
Participants are observed for potential complications and outcomes following the ERCP procedure.
Follow-up visits as needed within 30 days
Trial Site Locations
Total: 1 location
1
University of Calgary
Calgary, Alberta, Canada, T2N 4Z6
Actively Recruiting
Loading map...
Research Team
N
Nauzer Forbes, MD, MSc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here